G Sheng, Y Gao, Y Yang, H Wu - Frontiers in oncology, 2021 - frontiersin.org
Osteosarcoma is the most common primary bone malignancy in adolescents. Its high propensity to metastasize is the leading cause for treatment failure and poor prognosis …
K Ando, K Mori, F Verrecchia, B Marc, F Rédini… - Sarcoma, 2012 - Wiley Online Library
Osteosarcoma is the most frequent malignant primary bone tumor characterized by a high potency to form lung metastases which is the main cause of death. Unfortunately, the …
SK Denduluri, Z Wang, Z Yan, J Wang… - Journal of Biomedical …, 2016 - ncbi.nlm.nih.gov
Osteosarcoma (OS) is a devastating illness with rapid rates of dissemination and a poor overall prognosis, despite aggressive standard-of-care surgical techniques and combination …
Osteosarcoma is a malignant primary tumor of bone, arising from transformed progenitor cells with osteoblastic differentiation and osteoid production. While categorized as a rare …
F Fei, S Harada, S Wei, GP Siegal - … and Bone Metastases-From Bench to …, 2022 - Elsevier
Osteosarcoma is an extremely genetically unstable tumor with multiple numerical and structural chromosomal alterations. Chromothripsis and alternative lengthening of telomeres …
Treating metastatic osteosarcoma (OS) remains a challenge in oncology. Current treatment strategies target the primary tumour rather than metastases and have a limited efficacy in the …
C Khanna, TM Fan, R Gorlick, LJ Helman… - Clinical Cancer …, 2014 - AACR
Despite successful primary tumor treatment, the development of pulmonary metastasis continues to be the most common cause of mortality in patients with osteosarcoma. A …
GA Odri, J Tchicaya-Bouanga, DJY Yoon, D Modrowski - Cancers, 2022 - mdpi.com
Simple Summary Osteosarcomas are heterogeneous bone tumors with complex genetic and chromosomic alterations. The numerous patients with metastatic osteosarcoma have a very …
M Li, X Jin, H Li, G Wu, S Wang, C Yang, S Deng - BMC cancer, 2020 - Springer
Background Osteosarcoma is a primary malignant tumor originating from mesenchymal tissue, with a poor distant metastasis prognosis. The molecular mechanisms of …